<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC4353274/results/search/disease/results.xml">
  <result pre="Med MicrobiolCan J Infect Dis Med MicrobiolPGIThe Canadian Journal of" exact="Infectious" post="Diseases &amp;amp; Medical Microbiology1712-95321918-1493Pulsus Group Inc pmcid: 4353274idmm-26-e5 :"/>
  <result pre="MicrobiolCan J Infect Dis Med MicrobiolPGIThe Canadian Journal of Infectious" exact="Diseases" post="&amp;amp; Medical Microbiology1712-95321918-1493Pulsus Group Inc pmcid: 4353274idmm-26-e5 : AMMI"/>
  <result pre="Guidance on the use of antiviral drugs for influenza in" exact="acute" post="care facilities in Canada, 2014–2015 StiverH GrantMD1EvansGerald AMD2AokiFred YMD3AllenUpton"/>
  <result pre="[3], [4], [5], Correspondence: Dr Gerald A Evans, Division of" exact="Infectious" post="Diseases, Room 3013, Etherington Hall, Queen’s University, 94 Stuart"/>
  <result pre="for the use of antiviral drugs for influenza in the" exact="acute" post="care setting for this season are provided. The purpose"/>
  <result pre="provide an update on the management of patients in the" exact="acute" post="care setting infected with influenza viruses circulating in Canada"/>
  <result pre="concept was then approved by Association of Medical Microbiology and" exact="Infectious" post="Disease (AMMI) Canada. A first draft was cowritten by"/>
  <result pre="was then approved by Association of Medical Microbiology and Infectious" exact="Disease" post="(AMMI) Canada. A first draft was cowritten by all"/>
  <result pre="further review from the AMMI Canada Guidelines Committee and the" exact="Infectious" post="Diseases and Immunization Committee of the Canadian Paediatric Society."/>
  <result pre="review from the AMMI Canada Guidelines Committee and the Infectious" exact="Diseases" post="and Immunization Committee of the Canadian Paediatric Society. AMMI"/>
  <result pre="influenza A (H3N2) (9). Although the vaccine may still provide" exact="partial" post="protection, it is not expected to be optimal. Therefore,"/>
  <result pre="expected to be optimal. Therefore, vaccinated individuals may present to" exact="acute" post="care facilities with influenza-like illness (ILI) and require treatment"/>
  <result pre="DIAGNOSE INFLUENZA IN A PATIENT PRESENTING WITH ILI TO AN" exact="ACUTE" post="CARE FACILITY? During peaks of influenza activity in the"/>
  <result pre="the prevalence of influenza in the community relative to other" exact="respiratory" post="infections. In older patients with chronic obstructive pulmonary disease,"/>
  <result pre="community relative to other respiratory infections. In older patients with" exact="chronic" post="obstructive pulmonary disease, who have been vaccinated for influenza,"/>
  <result pre="to other respiratory infections. In older patients with chronic obstructive" exact="pulmonary disease," post="who have been vaccinated for influenza, only the presence"/>
  <result pre="fever &amp;gt;37.8° and myalgias correlated with influenza, but with a" exact="lower" post="positive predictive value of 41% (11). Other respiratory viruses,"/>
  <result pre="with a lower positive predictive value of 41% (11). Other" exact="respiratory" post="viruses, including but not limited to: respiratory syncytial virus"/>
  <result pre="value of 41% (11). Other respiratory viruses, including but not" exact="limited" post="to: respiratory syncytial virus (RSV), adenovirus, parainfluenza, rhinovirus, coronavirus"/>
  <result pre="41% (11). Other respiratory viruses, including but not limited to:" exact="respiratory" post="syncytial virus (RSV), adenovirus, parainfluenza, rhinovirus, coronavirus or human"/>
  <result pre="respiratory syncytial virus (RSV), adenovirus, parainfluenza, rhinovirus, coronavirus or human" exact="metapneumovirus infection," post="may account for those with non-influenza infection. The use"/>
  <result pre="Multiplex PCR testing allows for the diagnostic confirmation of other" exact="respiratory" post="viruses, although unlike influenza, there are presently no antiviral"/>
  <result pre="ROLE OF ANTIVIRALS IN THE MANAGEMENT OF INFLUENZA IN THE" exact="ACUTE" post="CARE SETTING? Treatment of patients with mild illness without"/>
  <result pre="ill patient because the inhaled powder deposits chiefly in the" exact="upper" post="airways. Zanamivir powder administered through ventilator circuits is contraindicated."/>
  <result pre="Table 2. Oseltamivir oral suspension may also be used by" exact="adult" post="patients who cannot swallow a capsule. If oseltamivir oral"/>
  <result pre="In these circumstances, repeat endotracheal samples should be sent for" exact="viral" post="PCR and susceptibility testing for oseltamivir resistance. Suspected oseltamivir"/>
  <result pre="zanamivir until results of antiviral susceptibility testing are available. Repeated" exact="viral" post="testing should be performed if the clinical condition fails"/>
  <result pre="discussion of the appropriate antibiotic management of patients with suspected" exact="bacterial" post="pneumonia is beyond the scope of this document. However,"/>
  <result pre="of the appropriate antibiotic management of patients with suspected bacterial" exact="pneumonia" post="is beyond the scope of this document. However, if"/>
  <result pre="of this document. However, if a patient presents with an" exact="acute" post="respiratory infection on a background of an influenza outbreak,"/>
  <result pre="this document. However, if a patient presents with an acute" exact="respiratory" post="infection on a background of an influenza outbreak, and"/>
  <result pre="document. However, if a patient presents with an acute respiratory" exact="infection" post="on a background of an influenza outbreak, and a"/>
  <result pre="infection on a background of an influenza outbreak, and a" exact="chest" post="radiograph demonstrates pulmonary infiltrates, primary influenza or secondary bacterial"/>
  <result pre="background of an influenza outbreak, and a chest radiograph demonstrates" exact="pulmonary" post="infiltrates, primary influenza or secondary bacterial pneumonia, or both,"/>
  <result pre="an influenza outbreak, and a chest radiograph demonstrates pulmonary infiltrates," exact="primary" post="influenza or secondary bacterial pneumonia, or both, are possibilities."/>
  <result pre="and a chest radiograph demonstrates pulmonary infiltrates, primary influenza or" exact="secondary" post="bacterial pneumonia, or both, are possibilities. Primary influenza pneumonia"/>
  <result pre="a chest radiograph demonstrates pulmonary infiltrates, primary influenza or secondary" exact="bacterial" post="pneumonia, or both, are possibilities. Primary influenza pneumonia typically"/>
  <result pre="primary influenza or secondary bacterial pneumonia, or both, are possibilities." exact="Primary" post="influenza pneumonia typically presents with severe shortness of breath"/>
  <result pre="or secondary bacterial pneumonia, or both, are possibilities. Primary influenza" exact="pneumonia" post="typically presents with severe shortness of breath and occurs"/>
  <result pre="(12). Clinicians should be aware that the presentation of a" exact="biphasic" post="illness with reappearance of fever after defervesence from a"/>
  <result pre="defervesence from a typical influenza illness might represent a complicating" exact="secondary" post="bacterial pneumonia. Bacterial pneumonia should be strongly suspected when"/>
  <result pre="from a typical influenza illness might represent a complicating secondary" exact="bacterial" post="pneumonia. Bacterial pneumonia should be strongly suspected when a"/>
  <result pre="influenza illness might represent a complicating secondary bacterial pneumonia. Bacterial" exact="pneumonia" post="should be strongly suspected when a typical influenza illness"/>
  <result pre="severely ill patients, appropriate antibiotics for community-acquired or nursing home-acquired" exact="pneumonia" post="should be instituted immediately, as well as NI antiviral"/>
  <result pre="PATIENT WITH SUSPECTED INFLUENZA? A detailed discussion of the appropriate" exact="infection" post="control measures for the management of patients with suspected"/>
  <result pre="ROLE OF ANTIVIRAL PROPHYLAXIS FOR PATIENTS AND HCWs? Post-exposure prophylaxis:" exact="Secondary" post="cases of influenza in family members of an index"/>
  <result pre="recommendation differs from that for residents and staff in long-term" exact="or chronic" post="care facilities. Pre-exposure prophylaxis for patients may be considered"/>
  <result pre="differs from that for residents and staff in long-term or" exact="chronic" post="care facilities. Pre-exposure prophylaxis for patients may be considered"/>
  <result pre="acknowledge the review and endorsement of the document by the" exact="Infectious" post="Diseases and Immunization Committee of the Canadian Paediatric Society."/>
  <result pre="the review and endorsement of the document by the Infectious" exact="Diseases" post="and Immunization Committee of the Canadian Paediatric Society. DISCLOSURES:"/>
  <result pre="REFERENCES 1.NicholsonKAokiFYOsterhausADet al.Efficacy and safety of oseltamivir in treatment of" exact="acute" post="influenza: A randomized controlled trialLancet200035518455010866439 2.collab: The MIST (Management"/>
  <result pre="Update number 228. &amp;lt;www.who.int/influenza/surveillance_monitoring/updates/latest_update_GIP_surveillance/en&amp;gt; (Accessed January 13, 2015). 10.BoivinGHardyITellierGMaziadeJPredicting influenza" exact="infections" post="during epidemics with the use of a clinical case"/>
  <result pre="case definitionClin Infect Dis2000311166911073747 11.NeuzilKMO’ConnorTZGorseGJNicholKLRecognizing influenza in older patients with" exact="chronic" post="obstructive pulmonary disease who have received influenza vaccineClin Infect"/>
  <result pre="Infect Dis2000311166911073747 11.NeuzilKMO’ConnorTZGorseGJNicholKLRecognizing influenza in older patients with chronic obstructive" exact="pulmonary disease" post="who have received influenza vaccineClin Infect Dis2003361697412522748 12.BisnoALGriffinJPVan EppsKANiellHBRytelMWPneumonia"/>
  <result pre="Dis2000311166911073747 11.NeuzilKMO’ConnorTZGorseGJNicholKLRecognizing influenza in older patients with chronic obstructive pulmonary" exact="disease" post="who have received influenza vaccineClin Infect Dis2003361697412522748 12.BisnoALGriffinJPVan EppsKANiellHBRytelMWPneumonia"/>
  <result pre="aged &amp;lt;2 years with influenzaJ Infect Dis20132077092023230059 14.collab: Centers for" exact="Disease" post="Control and PreventionInfluenza Antiviral Medications: Summary for Clinicians&amp;lt;www.cdc.gov/flu/professionals/antivirals/summary-clinicians.htm&amp;gt; (Accessed"/>
  <result pre="oral suspension&amp;lt;www.accessdata.fda.gov/drugsatfda_docs/nda/2012/021246Orig1s045_021087Orig1s062_tamiflu_toc.cfm&amp;gt; (Accessed January 13, 2015). 16.HalloranMEHaydenFGYangYLonginiIMJrMontoASAntiviral effects on influenza" exact="viral" post="transmission and pathogenicity: Observation-based trialsAm J Epidemiol20071652122117088311 TABLE 1"/>
  <result pre="twice daily Not recommended unless situation judged critical due to" exact="limited" post="data on use in this age group *Please note"/>
  <result pre="of 75 mg orally twice daily for adults (13–15). The" exact="American" post="Academy of Pediatrics recommended an oseltamivir treatment dose of"/>
  <result pre="25 mg per dose. 3.It is strongly suggested that an" exact="infectious disease" post="physician or clinical pharmacist be consulted in the case"/>
  <result pre="mg per dose. 3.It is strongly suggested that an infectious" exact="disease" post="physician or clinical pharmacist be consulted in the case"/>
  <result pre="based on data from the National Institute of Allergy and" exact="Infectious" post="Diseases Collaborative Antiviral Study Group using the infants’ postmenstrual"/>
  <result pre="on data from the National Institute of Allergy and Infectious" exact="Diseases" post="Collaborative Antiviral Study Group using the infants’ postmenstrual age"/>
  <result pre="in aerosolized solutions. Zanamivir is not recommended for persons with" exact="chronic" post="respiratory diseases such as asthma or chronic obstructive pulmonary"/>
  <result pre="aerosolized solutions. Zanamivir is not recommended for persons with chronic" exact="respiratory" post="diseases such as asthma or chronic obstructive pulmonary disease"/>
  <result pre="not recommended for persons with chronic respiratory diseases such as" exact="asthma" post="or chronic obstructive pulmonary disease that increase the risk"/>
  <result pre="recommended for persons with chronic respiratory diseases such as asthma" exact="or chronic" post="obstructive pulmonary disease that increase the risk of bronchospasm."/>
  <result pre="for persons with chronic respiratory diseases such as asthma or" exact="chronic" post="obstructive pulmonary disease that increase the risk of bronchospasm."/>
  <result pre="with chronic respiratory diseases such as asthma or chronic obstructive" exact="pulmonary disease" post="that increase the risk of bronchospasm. TABLE 2 Recommended"/>
  <result pre="chronic respiratory diseases such as asthma or chronic obstructive pulmonary" exact="disease" post="that increase the risk of bronchospasm. TABLE 2 Recommended"/>
  <result pre="TABLE 2 Recommended oseltamivir regimens for prevention and treatment of" exact="adult" post="patients with renal impairment (Tamiflu® Product Monograph, 2014) Creatinine"/>
  <result pre="following dosing regimen has been suggested for children based on" exact="limited" post="data: In children &amp;gt;1 year of age, after alternate"/>
  <result pre="a framework for guidance, it is strongly suggested that an" exact="infectious disease" post="physician, a specialist in renal insufficiency or clinical pharmacist"/>
  <result pre="framework for guidance, it is strongly suggested that an infectious" exact="disease" post="physician, a specialist in renal insufficiency or clinical pharmacist"/>
  <result pre="strongly suggested that an infectious disease physician, a specialist in" exact="renal insufficiency" post="or clinical pharmacist be consulted"/>
 </snippets>
</snippetsTree>
